Metis TechBio Refutes Media Claims of CSRC Supplemental Information Request

Bulletin Express05-26

Metis TechBio Co., Ltd. released a voluntary clarification stating that recent media reports alleging the China Securities Regulatory Commission (CSRC) has asked the company for additional listing information are factually incorrect and misleading.

The life-sciences group confirmed that it received the CSRC’s filing notice for the listing and full circulation of its H shares on 17 March 2026 and successfully debuted on the Main Board of The Stock Exchange of Hong Kong on 13 May 2026. Since receiving the filing notice, the company has not been approached by the CSRC for any supplemental information.

To safeguard its reputation, Metis TechBio signalled it may pursue legal action against parties disseminating false information. The board also reiterated that investors should rely solely on official company announcements and exercise caution when dealing in the firm’s securities.

Further disclosures will be made in accordance with Hong Kong listing rules, the Securities and Futures Ordinance, and other applicable regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1135122772?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-26 12:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135122772","market":"hk","top_or_hot":-1,"title":"Metis TechBio Refutes Media Claims of CSRC Supplemental Information Request","media":"Bulletin Express","content":"<p>Metis TechBio Co., Ltd. released a voluntary clarification stating that recent media reports alleging the China Securities Regulatory Commission (CSRC) has asked the company for additional listing information are factually incorrect and misleading.</p>\n<p>The life-sciences group confirmed that it received the CSRC’s filing notice for the listing and full circulation of its H shares on 17 March 2026 and successfully debuted on the Main Board of The Stock Exchange of Hong Kong on 13 May 2026. Since receiving the filing notice, the company has not been approached by the CSRC for any supplemental information.</p>\n<p>To safeguard its reputation, Metis TechBio signalled it may pursue legal action against parties disseminating false information. The board also reiterated that investors should rely solely on official company announcements and exercise caution when dealing in the firm’s securities.</p>\n<p>Further disclosures will be made in accordance with Hong Kong listing rules, the Securities and Futures Ordinance, and other applicable regulations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Metis TechBio Refutes Media Claims of CSRC Supplemental Information Request</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMetis TechBio Refutes Media Claims of CSRC Supplemental Information Request\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-26 12:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Metis TechBio Co., Ltd. released a voluntary clarification stating that recent media reports alleging the China Securities Regulatory Commission (CSRC) has asked the company for additional listing information are factually incorrect and misleading.</p>\n<p>The life-sciences group confirmed that it received the CSRC’s filing notice for the listing and full circulation of its H shares on 17 March 2026 and successfully debuted on the Main Board of The Stock Exchange of Hong Kong on 13 May 2026. Since receiving the filing notice, the company has not been approached by the CSRC for any supplemental information.</p>\n<p>To safeguard its reputation, Metis TechBio signalled it may pursue legal action against parties disseminating false information. The board also reiterated that investors should rely solely on official company announcements and exercise caution when dealing in the firm’s securities.</p>\n<p>Further disclosures will be made in accordance with Hong Kong listing rules, the Securities and Futures Ordinance, and other applicable regulations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07666","symbol_name":"剂泰科技-P","start_time":0,"source_url":"","article_id":"1135122772","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135122772","pubTimestamp":1779770565,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Metis TechBio Co., Ltd. released a voluntary clarification stating that recent media reports alleging the China Securities Regulatory Commission (CSRC) has asked the company for additional listing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"07666":"剂泰科技-P"},"translate_title":"Metis TechBio驳斥媒体对证监会补充信息要求的说法","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07666":1},"content_text":"Metis TechBio Co., Ltd. released a voluntary clarification stating that recent media reports alleging the China Securities Regulatory Commission (CSRC) has asked the company for additional listing information are factually incorrect and misleading.\nThe life-sciences group confirmed that it received the CSRC’s filing notice for the listing and full circulation of its H shares on 17 March 2026 and successfully debuted on the Main Board of The Stock Exchange of Hong Kong on 13 May 2026. Since receiving the filing notice, the company has not been approached by the CSRC for any supplemental information.\nTo safeguard its reputation, Metis TechBio signalled it may pursue legal action against parties disseminating false information. The board also reiterated that investors should rely solely on official company announcements and exercise caution when dealing in the firm’s securities.\nFurther disclosures will be made in accordance with Hong Kong listing rules, the Securities and Futures Ordinance, and other applicable regulations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1135122772","isCrawlerRequest":true}